Publications by authors named "Andreas Saltos"

Claim this Profile
U
Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non-Small Cell Lung Cancer.
Brian D Gonzalez, Xiaoyin Li, Lisa M Gudenkauf, Jerrin J Pullukkara, Laura B Oswald, Andreas N Saltos

JCO Clin Cancer Inform· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results.
Xiuning Le, Mike Hernandez, Simon Heeke, Andreas Saltos, John V Heymach

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Andreas N Saltos

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve -Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn, Andreas Saltos

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Andreas N Saltos

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical Care.
Aileen Y Alontaga, Pedro Cano, Hilal Ozakinci, John A Puskas, Paul A Stewart, Andreas N Saltos

J Mol Diagn· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Egbert F Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Andreas Saltos

Lancet Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race-inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
Sonam Puri, Andreas N Saltos, Jhanelle E Gray

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299.
Arkadiusz Z Dudek, Min X Xi, Katherine A Scilla, Hirva Mamdani, Benjamin C Creelan, Andreas Saltos

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an exon 19 deletion or exon 21 L858R mutation.
Sophia Gilardone, Ram Thapa, José Laborde, Michael Shafique, Andreas Saltos

J Thorac Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Andreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, Alberto A Chiappori, Scott J Antonia

Lung Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer.
Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, Nghi B Lam, Stephen A Rosenberg, Andreas N Saltos

Int J Radiat Oncol Biol Phys· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, Dana Foresman, Mengyu Xie, Andreas N Saltos

Cancer Immunol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.
Dung-Tsa Chen, Andreas N Saltos, Trevor Rose, Zachary J Thompson, Ram Thapa

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.
Kea Turner, Naomi C Brownstein, Zachary Thompson, Issam El Naqa, Yi Luo, Andreas Saltos

Radiother Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan in -Mutant Non-Small-Cell Lung Cancer.
Bob T Li, Egbert F Smit, Yasushi Goto, Kazuhiko Nakagawa, Hibiki Udagawa, Andreas N Saltos

N Engl J Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
Dung-Tsa Chen, Wenyaw Chan, Zachary J Thompson, Ram Thapa, Amer A Beg, Andreas N Saltos

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Benjamin C Creelan, Chao Wang, Jamie K Teer, Eric M Toloza, Jiqiang Yao, Andreas N Saltos

Nat Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Bradford A Perez, Sungjune Kim, Minhsuan Wang, Ahmad M Karimi, Chase Powell, Andreas Saltos

Int J Radiat Oncol Biol Phys· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
Andreas Saltos, Michael Shafique, Alberto Chiappori

Front Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the Impasse: Advances in Treatment of Small Cell Lung Cancer.
Andreas Saltos, Scott Antonia

Clin Chest Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally Advanced, Unresectable Non-Small Cell Lung Cancer.
Sonam Puri, Andreas Saltos, Bradford Perez, Xiuning Le, Jhanelle E Gray

Curr Oncol Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.
Jhanelle E Gray, Andreas Saltos, Tawee Tanvetyanon, Eric B Haura, Ben Creelan

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical associations of mucin 1 in human lung cancer and precancerous lesions.
Andreas Saltos, Farah Khalil, Michelle Smith, Jiannong Li, Michael Schell

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer.
Sandrine Niyongere, Andreas Saltos, Jhanelle E Gray

J Thorac Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis